Cargando…
Accès précoce autorisé à un traitement prophylactique des formes sévères de la Covid-19
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Masson SAS.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758903/ https://www.ncbi.nlm.nih.gov/pubmed/35043059 http://dx.doi.org/10.1016/S1773-035X(22)00011-9 |
| _version_ | 1784633000850358272 |
|---|---|
| author | Manus, Jean-Marie |
| author_facet | Manus, Jean-Marie |
| author_sort | Manus, Jean-Marie |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8758903 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Masson SAS. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87589032022-01-14 Accès précoce autorisé à un traitement prophylactique des formes sévères de la Covid-19 Manus, Jean-Marie Rev Francoph Lab Article Elsevier Masson SAS. 2021-12 2022-01-14 /pmc/articles/PMC8758903/ /pubmed/35043059 http://dx.doi.org/10.1016/S1773-035X(22)00011-9 Text en Copyright © 2021 Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Manus, Jean-Marie Accès précoce autorisé à un traitement prophylactique des formes sévères de la Covid-19 |
| title | Accès précoce autorisé à un traitement prophylactique des formes sévères de la Covid-19 |
| title_full | Accès précoce autorisé à un traitement prophylactique des formes sévères de la Covid-19 |
| title_fullStr | Accès précoce autorisé à un traitement prophylactique des formes sévères de la Covid-19 |
| title_full_unstemmed | Accès précoce autorisé à un traitement prophylactique des formes sévères de la Covid-19 |
| title_short | Accès précoce autorisé à un traitement prophylactique des formes sévères de la Covid-19 |
| title_sort | accès précoce autorisé à un traitement prophylactique des formes sévères de la covid-19 |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758903/ https://www.ncbi.nlm.nih.gov/pubmed/35043059 http://dx.doi.org/10.1016/S1773-035X(22)00011-9 |
| work_keys_str_mv | AT manusjeanmarie accesprecoceautoriseauntraitementprophylactiquedesformesseveresdelacovid19 |